Skip to main navigation
Skip to search
Skip to main content
Aston Research Explorer Home
Help & FAQ
Link opens in a new tab
Search content at Aston Research Explorer
Home
Research units
Profiles
Research Outputs
Datasets
Student theses
Activities
Press/Media
Prizes
Equipment
DPP6 gene disruption in a family with Gilles de la Tourette syndrome
Paolo Prontera
*
, Valerio Napolioni
, Valentina Ottaviani
, Daniela Rogaia
, Carmela Fusco
, Bartolomeo Augello
, Domenico Serino
, Valentina Parisi
, Laura Bernardini
, Giuseppe Merla
, Andrea E. Cavanna
, Emilio Donti
*
Corresponding author for this work
Aston University
University College London
University College Birmingham
Aston University
IRCCS Ospedale "Casa Sollievo della Sofferenza"
Ospedale Pediatrico Bambino Gesù
Università degli Studi di Perugia
Ospedale “S.M. della Misericordia”
Genetics and Biology
Birmingham and Solihull Mental Health NHS Foundation Trust
Research output
:
Contribution to journal
›
Article
›
peer-review
27
Link opens in a new tab
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'DPP6 gene disruption in a family with Gilles de la Tourette syndrome'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Gilles De La Tourette Syndrome
100%
Gene Disruption
100%
DPP6
100%
Tourette Syndrome
83%
Autism Spectrum Disorder
33%
Paternal Uncle
33%
Significant Level
16%
Familial Cases
16%
High-resolution
16%
PCR Analysis
16%
MRNA Level
16%
Messenger RNA (mRNA)
16%
Central Nervous System
16%
Quantitative PCR
16%
Duplication
16%
Heritability
16%
Tolerability
16%
Large Cohort
16%
Proband
16%
Membrane Glycoproteins
16%
Neurodevelopmental Disorders
16%
Haloperidol
16%
Psychiatric Comorbidity
16%
Phonic Tic
16%
Motor Tics
16%
Multiple Motors
16%
Molecular Link
16%
Exonic
16%
Microdeletion
16%
Haploinsufficiency
16%
SNP Array Analysis
16%
Uncertain Significance
16%
Array Comparative Genomic Hybridization (aCGH)
16%
RT-quantitative PCR
16%
Dyskinesia
16%
Italian Families
16%
First Exons
16%
Fluorescence in Situ Hybridization
16%
Genetic Architecture
16%
Biochemistry, Genetics and Molecular Biology
Gene Targeting
100%
Gene Disruption
100%
DPP6
100%
Membrane Protein
16%
Messenger RNA
16%
Downregulation
16%
Quantitative Reverse Transcription Polymerase Chain Reaction
16%
Real-Time Polymerase Chain Reaction
16%
Proband
16%
Comorbidity
16%
Exon
16%
Fluorescence in Situ Hybridization
16%
Haloperidol
16%
Array Comparative Genomic Hybridization
16%
Dopamine Antagonist
16%
Genetic Architecture
16%
Haploinsufficiency
16%
SNP Array
16%
Neuroscience
Tourette Syndrome
100%
Gene Disruption
100%
Pervasive Developmental Disorder
28%
Real-Time Polymerase Chain Reaction
28%
Messenger RNA
14%
Central Nervous System
14%
Glycoprotein
14%
In Situ Hybridization
14%
Haloperidol
14%
Neurodevelopmental Disorder
14%
Dyskinesia
14%
Psychiatric Co-Morbidity
14%
Dopamine Antagonist
14%
Haploinsufficiency
14%
Exon
14%